Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Ketamine in Pediatric Bipolar Disorder
NCT01504659Phase 3Terminated
- Sponsor
- Juvenile Bipolar Research Foundation
- Start
- Jul 2012
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in bipolar disorder (BD), sponsored by Juvenile Bipolar Research Foundation. Started Jul 2012; status: terminated.
02
Drugs
ketamine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01504659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01504659.